Ganesh Moorthy

4PUBLICATIONS
42CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 24, 2023
First-in-human Study of AZD5153, A Small-molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and Lymphoma.

Erika P Hamilton, Judy S Wang, Amit M Oza

|Aug 31, 2022
Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors.

Emerson A Lim, Johanna C Bendell, Gerald S Falchook

|Mar 05, 2022
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors.

Atish D Choudhury, Celestia S Higano, Johann S de Bono

|Apr 24, 2015
Safety, tolerability and pharmacokinetics of 2-pyridylacetic acid, a major metabolite of betahistine, in a phase 1 dose escalation study in subjects with ADHD.

Ganesh Moorthy, Floyd Sallee, Prasad Gabbita

Pageof 1

Frequent Collaborators

2 joint publications

Maureen M Hattersley

2 joint publications

Gayle P Pouliot

2 joint publications

Susanna V Ulahannan

2 joint publications

Manish R Patel